CAM
Cormorant Asset Management’s Axsome Therapeutics AXSM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.4M | Sell |
100,000
-150,000
| -60% | -$15.7M | 0.78% | 28 |
|
|
2025
Q1 | $29.2M | Sell |
250,000
-75,000
| -23% | -$8.75M | 2.19% | 15 |
|
|
2024
Q4 | $27.5M | Sell |
325,000
-75,000
| -19% | -$6.35M | 1.51% | 21 |
|
|
2024
Q3 | $35.9M | Hold |
400,000
| – | – | 1.91% | 20 |
|
|
2024
Q2 | $32.2M | Buy |
+400,000
| New | +$32.2M | 1.86% | 15 |
|
|
2023
Q3 | – | Sell |
-340,000
| Closed | -$24.4M | – | 54 |
|
|
2023
Q2 | $24.4M | Buy |
340,000
+40,000
| +13% | +$2.87M | 1.37% | 22 |
|
|
2023
Q1 | $18.5M | Sell |
300,000
-25,000
| -8% | -$1.54M | 1.22% | 22 |
|
|
2022
Q4 | $25.1M | Buy |
+325,000
| New | +$25.1M | 1.68% | 20 |
|
|
2022
Q3 | – | Sell |
-205,000
| Closed | -$7.85M | – | 75 |
|
|
2022
Q2 | $7.85M | Buy |
+205,000
| New | +$7.85M | 0.59% | 43 |
|
|
2021
Q2 | – | Sell |
-200,000
| Closed | -$11.3M | – | 105 |
|
|
2021
Q1 | $11.3M | Hold |
200,000
| – | – | 0.25% | 63 |
|
|
2020
Q4 | $16.3M | Sell |
200,000
-50,000
| -20% | -$4.07M | 0.39% | 50 |
|
|
2020
Q3 | $17.8M | Sell |
250,000
-100,000
| -29% | -$7.13M | 0.68% | 38 |
|
|
2020
Q2 | $28.8M | Sell |
350,000
-150,000
| -30% | -$12.3M | 1.1% | 25 |
|
|
2020
Q1 | $29.4M | Sell |
500,000
-100,000
| -17% | -$5.88M | 1.37% | 19 |
|
|
2019
Q4 | $62M | Buy |
+600,000
| New | +$62M | 2.47% | 9 |
|